ZhuZhou QianJin Pharmaceutical Co Ltd (600479) — Cash Flow-to-Debt Ratio
ZhuZhou QianJin Pharmaceutical Co Ltd (600479) has a Cash Flow-to-Debt Ratio of 0.17x as of September 2025, meaning its operating cash flow of CN¥288.83 Million could theoretically repay 0% of its total liabilities (CN¥1.66 Billion) in one year. See 600479 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ZhuZhou QianJin Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2002–2025)
Historical debt coverage capacity for ZhuZhou QianJin Pharmaceutical Co Ltd across 24 annual periods. Also explore ZhuZhou QianJin Pharmaceutical Co Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for ZhuZhou QianJin Pharmaceutical Co Ltd (2002–2025)
Year-by-year debt coverage analysis for ZhuZhou QianJin Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see how much is ZhuZhou QianJin Pharmaceutical Co Ltd worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.30x | CN¥480.24 Million | CN¥1.61 Billion | ▲ +5.8% |
| 2024 | 0.28x | CN¥398.77 Million | CN¥1.42 Billion | ▲ +4.8% |
| 2023 | 0.27x | CN¥443.12 Million | CN¥1.65 Billion | ▼ -33.5% |
| 2022 | 0.40x | CN¥733.47 Million | CN¥1.82 Billion | ▲ +13.1% |
| 2021 | 0.36x | CN¥485.57 Million | CN¥1.36 Billion | ▼ -3.5% |
| 2020 | 0.37x | CN¥542.37 Million | CN¥1.47 Billion | ▲ +181.2% |
| 2019 | 0.13x | CN¥155.49 Million | CN¥1.18 Billion | ▼ -64.3% |
| 2018 | 0.37x | CN¥383.47 Million | CN¥1.04 Billion | ▲ +35.7% |
| 2017 | 0.27x | CN¥283.47 Million | CN¥1.05 Billion | ▲ +82.5% |
| 2016 | 0.15x | CN¥140.88 Million | CN¥948.21 Million | ▲ +71.5% |
| 2015 | 0.09x | CN¥67.48 Million | CN¥779.17 Million | ▼ -60.2% |
| 2014 | 0.22x | CN¥183.34 Million | CN¥843.20 Million | ▲ +8.0% |
| 2013 | 0.20x | CN¥137.63 Million | CN¥683.92 Million | ▼ -40.9% |
| 2012 | 0.34x | CN¥197.82 Million | CN¥581.18 Million | ▲ +334.3% |
| 2011 | 0.08x | CN¥22.58 Million | CN¥288.10 Million | ▼ -62.2% |
| 2010 | 0.21x | CN¥39.13 Million | CN¥188.65 Million | ▼ -11.3% |
| 2009 | 0.23x | CN¥73.54 Million | CN¥314.48 Million | ▲ +15.4% |
| 2008 | 0.20x | CN¥37.20 Million | CN¥183.66 Million | ▼ -51.6% |
| 2007 | 0.42x | CN¥79.26 Million | CN¥189.30 Million | ▼ -41.0% |
| 2006 | 0.71x | CN¥120.12 Million | CN¥169.13 Million | ▲ +88.8% |
| 2005 | 0.38x | CN¥76.50 Million | CN¥203.38 Million | ▲ +202.4% |
| 2004 | 0.12x | CN¥18.45 Million | CN¥148.38 Million | ▼ -54.1% |
| 2003 | 0.27x | CN¥50.96 Million | CN¥188.23 Million | ▲ +676.9% |
| 2002 | 0.03x | CN¥6.07 Million | CN¥174.31 Million | — |